Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Assets: 2014-2024

Historic Return on Assets for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to 0.10%.

  • Amphastar Pharmaceuticals' Return on Assets fell 4.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.10% for FY2024, which is 2.00% down from last year.
  • As of FY2024, Amphastar Pharmaceuticals' Return on Assets stood at 0.10%, which was down 20.54% from 0.12% recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Assets peaked at 0.12% during FY2022, and registered a low of 0.00% during FY2020.
  • Moreover, its 3-year median value for Return on Assets was 0.12% (2023), whereas its average is 0.11%.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Assets declined by 11bps in 2020 and then rose by 10bps in 2021.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Return on Assets stood at 0.00% in 2020, then increased by 10bps to 0.10% in 2021, then grew by 3bps to 0.12% in 2022, then remained steady at 0.12% in 2023, then declined by 2bps to 0.10% in 2024.